{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:20:06Z","timestamp":1761060006910},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.amjcard.2015.09.014","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T22:57:04Z","timestamp":1443567424000},"page":"S1-S9","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S1","title":["The Role of I-123 Metaiodobenzylguanidine Imaging in Management of Patients With Heart Failure"],"prefix":"10.1016","volume":"116","author":[{"given":"David","family":"Wolinsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hendel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Cerqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagat","family":"Narula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagmeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslee","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oussama","family":"Wazni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Farnum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2015.09.014_bib1","series-title":"Heart Failure","author":"Hobbs","year":"2014"},{"key":"10.1016\/j.amjcard.2015.09.014_bib2","first-page":"e242","article-title":"Heart disease and stroke statistics\u20142015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.09.014_bib3","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart\u00a0failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.09.014_bib4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jacc.2008.10.025","volume":"53","author":"Tamaki","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.014_bib5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12350-013-9707-1","article-title":"Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively","volume":"20","author":"Schwartz","year":"2013","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.014_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccl.2008.12.007","article-title":"Cardiac neuronal imaging at the edge of clinical application","volume":"27","author":"Travin","year":"2009","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.amjcard.2015.09.014_bib7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/01.CIR.94.4.690","article-title":"Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators","volume":"94","author":"Benedict","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.09.014_bib8","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1056\/NEJMoa043938","article-title":"Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both","volume":"352","author":"Solomon","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2015.09.014_bib9","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.110.976092","article-title":"Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop","volume":"122","author":"Fishman","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.09.014_bib10","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCULATIONAHA.111.023838","article-title":"Epidemiology and genetics of sudden cardiac death","volume":"125","author":"Deo","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.09.014_bib11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/CIRCEP.113.001034","article-title":"Public health burden of sudden cardiac death in the United States","volume":"7","author":"Stecker","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.amjcard.2015.09.014_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1056\/NEJMp1111467","article-title":"Time for a change: a new approach to ICD replacement","volume":"366","author":"Kramer","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2015.09.014_bib13","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/europace\/euq329","article-title":"Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischemic or non-ischemic heart disease: a systematic review and meta-analysis","volume":"12","author":"Theuns","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2015.09.014_bib14","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1161\/CIRCULATIONAHA.105.577262","article-title":"Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II","volume":"113","author":"Goldenberg","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.09.014_bib15","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2012.12.017","volume":"61","author":"Russo","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.014_bib16","first-page":"174","article-title":"Cardioverter defibrillator therapy in the primary and secondary prevention of sudden cardiac death","volume":"16","author":"Zitron","year":"2012","journal-title":"Appl Cardiopulm Pathophysiol"},{"key":"10.1016\/j.amjcard.2015.09.014_bib17","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1161\/CIRCULATIONAHA.113.002539","article-title":"Frequency and determinants of implantable cardioverter defibrillator deployment among primary prevention candidates with subsequent sudden cardiac arrest in the community","volume":"128","author":"Narayanan","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.09.014_bib18","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.jacc.2014.03.025","article-title":"Appropriateness of primary prevention implantable cardioverter defibrillators at time of generator replacement: are indications still met?","volume":"63","author":"Kini","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.014_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/oxfordjournals.eurheartj.a015273","article-title":"Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function","volume":"18","author":"Otterstad","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2015.09.014_bib20","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jacc.2004.05.068","article-title":"Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: a comparison with magnetic resonance imaging","volume":"44","author":"Malm","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.014_bib21","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1023\/B:CEPR.0000023159.96742.d2","article-title":"Risk stratification for sudden death: do we need anything more than ejection fraction?","volume":"7","author":"Buxton","year":"2003","journal-title":"Card Electrophysiol Rev"},{"issue":"suppl 2","key":"10.1016\/j.amjcard.2015.09.014_bib22","doi-asserted-by":"crossref","first-page":"ii25","DOI":"10.1093\/europace\/eur085","article-title":"Cardioverter-defibrillators: a cost or an investment?","volume":"13","author":"Leyva","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2015.09.014_bib23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.amjcard.2007.04.024","article-title":"Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of \u226435%","volume":"100","author":"Thomas","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.014_bib24","doi-asserted-by":"crossref","first-page":"167.e17","DOI":"10.1016\/j.amjmed.2005.08.021","article-title":"Disparities in the use of primary prevention and defibrillator therapy among blacks and women","volume":"119","author":"Gauri","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2015.09.014_bib25","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1001\/jama.298.13.1517","article-title":"Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death","volume":"298","author":"Curtis","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2015.09.014_bib26","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jacc.2008.05.058","article-title":"A\u00a0critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death","volume":"52","author":"Tung","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.014_bib27","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.jacc.2006.02.049","article-title":"The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators","volume":"47","author":"Reynolds","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.014_bib28","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.hrthm.2008.09.020","article-title":"Outcome of advisory implantable cardioverter-defibrillator replacement: one-year follow-up","volume":"5","author":"Gould","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjcard.2015.09.014_bib29","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.jacc.2005.02.077","article-title":"The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators","volume":"45","author":"Hauser","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.014_bib30","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/europace\/eus006","article-title":"Cost implications of defibrillator lead failures","volume":"14","author":"Groarke","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2015.09.014_bib31","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1161\/CIRCULATIONAHA.110.976076","article-title":"Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry","volume":"122","author":"Poole","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.09.014_bib32","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1185\/03007990802695037","article-title":"Cost-benefit analysis of primary prevention of sudden cardiac death with an implantable cardioverter defibrillator versus amiodarone in Canada","volume":"25","author":"Deniz","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.amjcard.2015.09.014_bib33","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/0003-4819-135-10-200111200-00007","article-title":"Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction","volume":"135","author":"Sanders","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2015.09.014_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/CIRCULATIONAHA.105.581884","article-title":"Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)","volume":"114","author":"Mark","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.09.014_bib35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1067\/mhj.2002.125501","article-title":"Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator","volume":"144","author":"Owens","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2015.09.014_bib36","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.jacc.2007.02.058","article-title":"Effect of cardiac and noncardiac conditions on survival after defibrillator implantation","volume":"49","author":"Lee","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.014_bib37","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The Seattle heart failure model: prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2015.09.014_bib38","first-page":"341","article-title":"The evolution in the use of MIBG in more than 25 years of experimental and clinical applications","volume":"52","author":"Rufini","year":"2008","journal-title":"Q\u00a0J Nucl Med Mol Imaging"},{"key":"10.1016\/j.amjcard.2015.09.014_bib39","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","article-title":"Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study","volume":"55","author":"Jacobson","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.014_bib40","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00259-012-2180-2","article-title":"Reproducibility of MIBG myocardial scintigraphy in patients with heart failure","volume":"39","author":"Veltman","year":"2012","journal-title":"Eur J Nucl Med Imaging"},{"key":"10.1016\/j.amjcard.2015.09.014_bib41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00259-007-0639-3","article-title":"I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study","volume":"35","author":"Agostini","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.amjcard.2015.09.014_bib42","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s12350-012-9603-0","article-title":"Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging","volume":"19","author":"Ketchum","year":"2012","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.amjcard.2015.09.014_bib43","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jcmg.2013.02.007","article-title":"A\u00a0pooled analysis of multicenter cohort studies of (123)I-MIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure","volume":"6","author":"Nakata","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2015.09.014_bib44","unstructured":"Adreview Prescribing Information. GE Healthcare, 2013. Available at: http:\/\/www3.gehealthcare.com\/en\/products\/categories\/nuclear_imaging_agents#item2info. Accessed August 28, 2014."},{"key":"10.1016\/j.amjcard.2015.09.014_bib45","unstructured":"CMS HOPPS payment. Available at: http:\/\/snmmi.files.cms-plus.com\/FileDownloads\/CodingAndReimbursement\/HOPPS%202013F%20vs%202014P3.pdf. Accessed August 28, 2014."},{"key":"10.1016\/j.amjcard.2015.09.014_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcmg.2009.11.002","article-title":"Adrenergic excess, hNET1 down-regulation, and compromised mIBG uptake in heart failure","volume":"3","author":"Haider","year":"2010","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915019931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914915019931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T02:46:45Z","timestamp":1655347605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914915019931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":46,"alternative-id":["S0002914915019931"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.09.014","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of I-123 Metaiodobenzylguanidine Imaging in Management of Patients With Heart Failure","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2015.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}